Valeant Pharma (VRX) Lower as Philidor Charges Said Imminent

November 17, 2016 9:29 AM EST

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Valeant Pharma (NYSE: VRX) is modestly lower pre-open on reports charges are coming imminently at Philidor. Shares are down 1%.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Rumors, Short Sales, Trader Talk

Related Entities

Pre Market Movers

Add Your Comment